Clinical trials: Claudication (Finding)

Peripheral Arterial Disease, Claudication (Finding)

Cilostazol After Lower Extremity Arterial Revascularization Trial

• Terminated
• Age: 35 years and older
• Phase 4
• Results posted

Twenty patients will be recruited to CLEAR. Ten will be randomized to the treatment arm (Cilostazol) and tenwill be randomized to the control group. Patients randomized to the treatment arm will receive Cilostazol for 90 days.

Trial name

CLEAR (NCT02374957)

Testing

Cilostazol

Where

United States

Volunteers

20 people

Sponsor

Wake Forest University Health Sciences